Description
Tagrisso 40mg Tablet 10’S tagrisso 40mg tablets (10’s) is a specialized medication designed for the treatment of certain types of non-small cell lung cancer (nsclc). This medication, specifically, is indicated for patients with mutated EGFR-positive NSCLC who have progressed on or after prior therapy. The active ingredient in Tagrisso is osimertinib, a third-generation tyrosine kinase inhibitor. Each tablet contains 40mg of osimertinib and is available in packs of 10. By targeting the EGFR mutation, Tagrisso helps to slow or stop the growth of cancer cells, potentially improving survival and quality of life for eligible patients. Always consult with a healthcare provider to determine if Tagrisso is right for you.
Reviews
There are no reviews yet.